Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach
- PMID: 11031690
- DOI: 10.3109/13550280009018301
Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach
Abstract
The rabies virus glycoprotein (G) gene of the highly neuroinvasive and neurotropic strains SHBRV-18, CVS-N2c, and CVS-B2c was introduced into the non-neuroinvasive and less neurotropic SN-10 strain to provide further insight into the role of G in the pathogenesis of rabies. Phenotypic analyses of the recombinant viruses revealed, as expected, that the neurotropism of a particular rabies virus strain was a function of its G. Nevertheless, the pathogenicity of the recombinant viruses was, in every case, markedly lower than that of the wild-type viruses suggesting that while the G dictates neurotropism, other viral attributes are also important in pathogenesis. The low pathogenicity of the recombinant viruses is at least in part due to a strong increase in transcription activity. On the other hand, the production of infectious virus by the R-SHB18 recombinant virus-infected cells was significantly delayed by comparison with SHBRV-18 wild-type virus infected-cells. Replacement of the R-SHB18 G cytoplasmic domain, transmembrane domain, and stem region with its SN-10 G counterparts neither results in a significant increase in budding efficiency nor an increase in pathogenicity. These results suggest that an optimal match of the cytoplasmic domain of G with the matrix protein may not be sufficient for maximal virus budding efficiency, which is evidently a major factor of virus pathogenicity. Our studies indicate that to maintain pathogenicity, the interactions between various structural elements of rabies virus must be highly conserved and the expression of viral proteins, in particular the G protein, must be strictly controlled.
Similar articles
-
Rabies virus quasispecies: implications for pathogenesis.Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3152-6. doi: 10.1073/pnas.95.6.3152. Proc Natl Acad Sci U S A. 1998. PMID: 9501231 Free PMC article.
-
Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures.J Virol. 1999 Jan;73(1):510-8. doi: 10.1128/JVI.73.1.510-518.1999. J Virol. 1999. PMID: 9847357 Free PMC article.
-
Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America.Proc Natl Acad Sci U S A. 1996 May 28;93(11):5653-8. doi: 10.1073/pnas.93.11.5653. Proc Natl Acad Sci U S A. 1996. PMID: 8643632 Free PMC article.
-
New approaches to the development of live attenuated rabies vaccines.Hybrid Hybridomics. 2002 Apr;21(2):129-34. doi: 10.1089/153685902317401735. Hybrid Hybridomics. 2002. PMID: 12031103 Review.
-
[Rabies virus glycoprotein: structure, immunogenicity and pathogenic role].Rev Chilena Infectol. 2008 Apr;25(2):S14-8. Epub 2008 Apr 16. Rev Chilena Infectol. 2008. PMID: 18425218 Review. Spanish.
Cited by
-
Rabies Internalizes into Primary Peripheral Neurons via Clathrin Coated Pits and Requires Fusion at the Cell Body.PLoS Pathog. 2016 Jul 27;12(7):e1005753. doi: 10.1371/journal.ppat.1005753. eCollection 2016 Jul. PLoS Pathog. 2016. PMID: 27463226 Free PMC article.
-
Double-labeled rabies virus: live tracking of enveloped virus transport.J Virol. 2008 Jan;82(1):237-45. doi: 10.1128/JVI.01342-07. Epub 2007 Oct 10. J Virol. 2008. PMID: 17928343 Free PMC article.
-
Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus Vaccine.Trop Med Infect Dis. 2017 Aug 9;2(3):37. doi: 10.3390/tropicalmed2030037. Trop Med Infect Dis. 2017. PMID: 30270894 Free PMC article.
-
Interspecies protein substitution to investigate the role of the lyssavirus glycoprotein.J Gen Virol. 2013 Feb;94(Pt 2):284-292. doi: 10.1099/vir.0.048827-0. Epub 2012 Oct 24. J Gen Virol. 2013. PMID: 23100360 Free PMC article.
-
A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.J Gen Virol. 2005 May;86(Pt 5):1435-1440. doi: 10.1099/vir.0.80844-0. J Gen Virol. 2005. PMID: 15831955 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical